US hedge fund Pentwater Capital has emerged as the buyer of the 23 per cent stake in Irish life science investment company Malin Corp that was sold in recent weeks by troubled...
Keep Reading →
October 8 - Hedge Funds, Insider Trading - Comments
In a message he wrote shortly before his death, the legendary oil magnate T.
Keep Reading →
September 20 - Hedge Funds, Insider Trading - Comments
Pershing Square bucks a down market with August gains.
Keep Reading →
September 4 - Hedge Funds, Insider Trading - Comments
BOSTON (Reuters) - Billionaire investor Daniel Loeb said on Friday that his hedge fund Third Point LLC will vote against the planned merger of United Technologies Corp (UTX.N) ...
Keep Reading →
June 28 - Hedge Funds, Insider Trading - Comments
You can access the original SEC filing by clicking here.
Keep Reading →
August 1 - Hedge Funds - Comments
You can access the original SEC filing by clicking here.
Keep Reading →
May 25 - Hedge Funds - Comments
You can access the original SEC filing by clicking here.
Keep Reading →
May 15 - Hedge Funds - Comments
It’s been a busy quarter in the biotechnology space, but it’s not over yet.
Keep Reading →
March 14 - News, Stock Analysis - Comments
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) and Palatin Technologies, Inc.
Keep Reading →
January 10 - Market Movers, News, Stock Analysis - Comments
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) took a big hit yesterday, as the company announced its second-quarter earnings and missed on expectations – well, sort of.
Keep Reading →
August 11 - News, Stock Analysis - Comments
Sweden-based healthcare focused long/short equity hedge fund Healthinvest Partners AB was founded in 2006 by Anders Hallberg and Carl Bennet.
Keep Reading →
February 15 - Hedge Funds, News - Comments
The markets have continued to tumble in the second week of 2016, with all major U.S stock indexes now down today after a mild rally earlier in the day.
Keep Reading →
January 11 - Market Movers, News - Comments
The shareholders of CIT Group Inc. (NYSE:CIT), AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), Avis Budget Group Inc.
Keep Reading →
November 3 - Market Movers, News - Comments
For the last year or so, many investors have been seeking profitable opportunities in the biotech sector, which has sent the shares of many stocks higher.
Keep Reading →
October 23 - Hedge Funds, News - Comments
William Leland Edwards' Palo Alto Investors is a reputable fund with a strong focus and in-depth knowledge of healthcare stocks, a sector that accounts for more than 80% of ...
Keep Reading →
July 17 - Hedge Fund Analysis, Hedge Funds, News - Comments
Our research has shown us that hedge funds are particularly adept at generating large returns from small-cap stocks.
Keep Reading →
February 20 - Hedge Fund Analysis, Hedge Funds, News - Comments
Deerfield Management, managed by James E. Flynn, has disclosed upping its stake in AMAG Pharmaceuticals Inc. (NASDAQ:AMAG). A new filing with the U.S.
Keep Reading →
August 11 - Hedge Funds, News - Comments
Jacob Gottlieb and his fund, Visium Asset Management, have upped their interest in Brookdale Senior Living, Inc.
Keep Reading →
April 23 - Hedge Funds, News - Comments
In three recent filings, Kevin Kotler’s Broadfin Capital has revealed adding three companies: Corium International Inc (NASDAQ:CORI), AMAG Pharmaceuticals Inc.
Keep Reading →
April 17 - Hedge Funds, News - Comments
Visium Asset Management, managed by Jacob Gottlieb, disclosed in an SEC filing that it initiated a 1.6 million position in AMAG Pharmaceuticals Inc.
Keep Reading →
March 7 - Hedge Funds, News - Comments
In the 21st century investor’s toolkit, there are many methods shareholders can use to track publicly traded companies.
Keep Reading →
September 9 - News - Comments
If you were to ask many of your peers, hedge funds are assumed to be overrated, outdated financial vehicles of a forgotten age.
Keep Reading →
August 22 - News - Comments
In today’s marketplace, there are many metrics investors can use to watch stocks. Two of the most under-the-radar are hedge fund and insider trading activity.
Keep Reading →
July 1 - News - Comments
In today’s marketplace, there are many indicators shareholders can use to watch the equity markets.
Keep Reading →
June 25 - News - Comments
If you'd ask most market participants, hedge funds are seen as slow, outdated investment vehicles of years past.
Keep Reading →
June 19 - News - Comments
Is AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) the right pick for your portfolio? Prominent investors are taking a pessimistic view.
Keep Reading →
June 12 - News - Comments
Gloom, despair, and agony. Shareholders of at least three health-care stocks experienced one or more of these feelings over the past few days.
Keep Reading →
May 28 - News - Comments
Martin Shkreli, MSMB Capital has succeeded in derailing the acquisition of Allos Therapeutics Inc. (ALTH) by AMAG Pharmaceuticals Inc. (AMAG).
Keep Reading →
October 21 - Hedge Funds - Comments
